Monoclonal Antibody: Targeted Therapy of Cancer

C. Vogel, M.A. Cobleigh, D. Tripathy, J.C. Gutheil, L.N. Harris, L. Fehrenbacher, D.J. Slamon, M. Murphy, W.F. Novotny, M. Burchmore, S. Shak, S.J. Stewart, First-line, single-agent Herceptin(trastuzumab) in metastatic breast cancer: a preliminary report. European Journal of Cancer. ,vol. 37, pp. 25- 29 ,(2001) , 10.1016/S0959-8049(00)00405-6

Holger Nückel, Ulrich H. Frey, Alexander Röth, Ulrich Dührsen, Winfried Siffert, Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity European Journal of Pharmacology. ,vol. 514, pp. 217- 224 ,(2005) , 10.1016/J.EJPHAR.2005.03.024

Neus Villamor, Emili Montserrat, Dolors Colomer, Mechanism of action and resistance to monoclonal antibody therapy Seminars in Oncology. ,vol. 30, pp. 424- 433 ,(2003) , 10.1016/S0093-7754(03)00261-6

Rafael G. Amado, Michael Wolf, Marc Peeters, Eric Van Cutsem, Salvatore Siena, Daniel J. Freeman, Todd Juan, Robert Sikorski, Sid Suggs, Robert Radinsky, Scott D. Patterson, David D. Chang, Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer Journal of Clinical Oncology. ,vol. 26, pp. 1626- 1634 ,(2008) , 10.1200/JCO.2007.14.7116

V. Grunwald, M. Hidalgo, Developing Inhibitors of the Epidermal Growth Factor Receptor for Cancer Treatment JNCI Journal of the National Cancer Institute. ,vol. 95, pp. 851- 867 ,(2003) , 10.1093/JNCI/95.12.851

John D Hainsworth, Prolonging remission with rituximab maintenance therapy. Seminars in Oncology. ,vol. 31, pp. 17- 21 ,(2004) , 10.1053/J.SEMINONCOL.2003.12.005

Marion Harris, Monoclonal antibodies as therapeutic agents for cancer Lancet Oncology. ,vol. 5, pp. 292- 302 ,(2004) , 10.1016/S1470-2045(04)01467-6

Michael J. Keating, Ian Flinn, Vinay Jain, Jacques-Louis Binet, Peter Hillmen, John Byrd, Maher Albitar, Lee Brettman, Pedro Santabarbara, Bret Wacker, Kanti R. Rai, Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study. Blood. ,vol. 99, pp. 3554- 3561 ,(2002) , 10.1182/BLOOD.V99.10.3554

S. C. Tang, K. Hewitt, M. D. Reis, N. L. Berinstein, Immunosuppressive Toxicity of CAMPATH®1H Monoclonal Antibody in the Treatment of Patients with Recurrent Low Grade Lymphoma Leukemia & Lymphoma. ,vol. 24, pp. 93- 101 ,(1996) , 10.3109/10428199609045717

Herbert Hurwitz, Louis Fehrenbacher, William Novotny, Thomas Cartwright, John Hainsworth, William Heim, Jordan Berlin, Ari Baron, Susan Griffing, Eric Holmgren, Napoleone Ferrara, Gwen Fyfe, Beth Rogers, Robert Ross, Fairooz Kabbinavar, None, BEVACIZUMAB PLUS IRINOTECAN, FLUOROURACIL, AND LEUCOVORIN FOR METASTATIC COLORECTAL CANCER The New England Journal of Medicine. ,vol. 350, pp. 2335- 2342 ,(2004) , 10.1056/NEJMOA032691